Lookup NU author(s): Dr Louise Tailford,
Dr Claire Dumon,
Professor Harry Gilbert
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Enzyme inhibition through mimicry of the transition state is a major area for the design of new therapeutic agents. Emerging evidence suggests that many retaining glycosidases that are active on α- or β-mannosides harness unusual B2,5 (boat) transition states. Here we present the analysis of 25 putative β-mannosidase inhibitors, whose Ki values range from nanomolar to millimolar, on the Bacteroides thetaiotaomicron β-mannosidase BtMan2A. B2,5 or closely related conformations were observed for all tightly binding compounds. Subsequent linear free energy relationships that correlate log Ki with log Km/k cat for a series of active center variants highlight aryl-substituted mannoimidazoles as powerful transition state mimics in which the binding energy of the aryl group enhances both binding and the degree of transition state mimicry. Support for a B2,5 transition state during enzymatic β-mannosidase hydrolysis should also facilitate the design and exploitation of transition state mimics for the inhibition of retaining α-mannosidases - an area that is emerging for anticancer therapeutics. © 2008 Nature Publishing Group.
Author(s): Tailford LE, Offen WA, Smith NL, Dumon C, Morland C, Gratien J, Heck M-P, Stick RV, Blériot Y, Vasella A, Gilbert HJ, Davies GJ
Publication type: Article
Publication status: Published
Journal: Nature Chemical Biology
ISSN (print): 1552-4450
ISSN (electronic): 1552-4469
Publisher: Nature Publishing Group
PubMed id: 18408714
Altmetrics provided by Altmetric